Key facts
- IQ Endoscopes’s last known valuation is $19.5M (Jan 2023).
- It has raised $14.5M; the latest was Later Stage VC in Feb 2025.
- Notable investors include OurCrowd, BGF (Financial Services), Development Bank of Wales, Australian Unity, BNP Paribas — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for IQ Endoscopes
- ·The full record, as it builds
Funding rounds
No funding rounds for IQ Endoscopes are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IQ Endoscopes
Developer of a healthcare technology designed to provide images of the full length of the gut, to help in diagnostics and therapeutic procedures. The company's technology offers early detection of cancers, enabling the medical industry to reduce fixed costs and move decision-making from fixed to operational costs.
- Sector
- Healthcare
- HQ
- Chepstow, United Kingdom
- Founded
- 2015
- Employees
- 27
- Website
- iqendoscopes.com/
- Ownership
- Privately Held (backing)
IQ Endoscopes doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IQ Endoscopes shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IQ Endoscopes in its N-PORT filings yet. We sweep new filings monthly.